Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00866333. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT00322387. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00004031. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00253630. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00109967. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT02408861. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
ClinicalTrials.gov study NCT00001575. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01076543. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01190449. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00295932. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01882803. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00248534. IPD Sharing: NO. Countries: 1. Publications: 1.
Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT00705250. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)
ClinicalTrials.gov study NCT00912223. IPD Sharing: YES. Countries: 1. Publications: 1.
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02253992. IPD Sharing: Not stated. Countries: 4. Publications: 1.
CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00290472. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT01144364. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Peri-transplant RT for patients undergoing autologous SCT for Hodgkin lymphoma with BEAM or BCV
<p>This is a multi-institutional database of patients who underwent autologous stem cell transplantation for Hodgkin lymphoma with BEAM or BCV.</p>
Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma
<p>Lack of accurate methods for early lymphoma detection limits the ability to cure patients. Patients with Non-Hodgkin lymphomas (NHL) who present with advanced disease have worse outcomes.</p> <p>We developed a DNA methylation-based prediction tool for NHL, based on blood samples collected prospectively from 278 apparently healthy patients who were followed for up to 16 years to monitor for NHL development. A predictive score was developed using machine learning methods in a robust training/validation framework.</p> <p>Our predictive score incorporates CpG DNA methylation at 135 genomic positions, with higher scores predicting higher risk. It was 85% and 78% accurate for identifying patients at risk of developing future NHL, in patients with high or low epigenetic mitotic clock respectively, in a validation cohort. It was also sensitive at detecting active NHL (96.3% accuracy) and healthy status (95.6% accuracy) in additional independent cohorts. Scores optimized for specific NHL subtypes showed significant but lower accuracy for predicting other subtypes. Our score incorporates hyper-methylation of Polycomb and <em>HOX</em> genes, which have roles in NHL development, as well as <em>PAX5</em> - a master transcriptional regulator of B-cell fate. Subjects with higher risk scores showed higher regulatory T-cells, memory B-cells, but lower naïve T helper lymphocytes fractions in the blood.</p> <p>A score based on DNA methylation in blood is accurate at predicting NHL development with lead time of up to 16 years. Future prospective studies will be required to confirm the utility of our signature for managing patients who are at high risk for developing future NHL.</p>
Raw data of "Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines" article.
<p>This is the dataset with used raw data regarding preparation of the manuscript entitled "Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines" (10.1371/journal.pone.0283186).</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.